Skip to main content
Fig. 7 | Journal of Translational Medicine

Fig. 7

From: eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma

Fig. 7

Immune characteristics between eIF6 high and low expression groups. A Tumor immune status of the high (n = 81) and low eIF6 expression groups (n = 81) using xCell microenvironment scores in the TCGA datasets. B Lollipop plot showing the correlation between the relative abundance of immune cells and eIF6 gene expression levels in the TCGA-ESCA samples determined using the ssGSEA method. C Violin plot displaying differences in 13 immune cell types between low and high eIF6 expression groups. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page